World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 13 January 2015
Main ID:  ISRCTN34856269
Date of registration: 23/01/2004
Prospective Registration: No
Primary sponsor: Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Public title: A prospective randomised controlled trial of open access endoscopy and near patient testing for Helicobacter pylori antibodies in primary care
Scientific title:
Date of first enrolment: 01/03/1995
Target sample size: 430
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN34856269
Study type:  Interventional
Study design:  Randomised controlled trial (Treatment)  
Phase: 
Countries of recruitment
United Kingdom
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: FDR    Hobbs
Address:  The Department of Primary Care and General Practice Medical School University of Birmingham Edgbaston B15 2TT Birmingham United Kingdom
Telephone: +44 (0)121 414 3765
Email: f.d.r.hobbs@bham.ac.uk
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Dyspeptic patients
2. Aged 18 years and over (either sex)
3. Helicobacter pylori positive

Exclusion criteria: 1. Previous endoscopy
2. Positive barium meal examination in the past three years
3. Unable to give informed consent
4. Unfit for endoscopy


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Peptic ulcer disease
Digestive System
Gastro-oesophageal reflux disease
Intervention(s)
Under 50 years: Near patient testing for H. pylori (Helisal rapid blood, Cortecs diagnostics, UK) and open-access endoscopy if positive
Over 50 years: initial open access endoscopy
Controls: prescribing or specialist referral at GP's discretion
Primary Outcome(s)
Cost-effectiveness based on symptomatic improvement and health resource utilisation for dyspepsia at 12 months.
Secondary Outcome(s)
1. Quality of life (QoL)
2. Patient satisfaction
Secondary ID(s)
PSI03-07
Source(s) of Monetary Support
NHS Primary and Secondary Care Interface National Research and Development Programme (UK)
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history